Molecular Therapy - Methods & Clinical Development

Slides:



Advertisements
Similar presentations
Molecular Therapy - Methods & Clinical Development
Advertisements

Molecular Therapy - Methods & Clinical Development
Volume 9, Issue 5, Pages (November 2017)
Molecular Therapy - Methods & Clinical Development
Molecular Therapy - Nucleic Acids
Volume 16, Issue 3, Pages (March 2008)
Long-Term Rescue of a Lethal Inherited Disease by Adeno-Associated Virus–Mediated Gene Transfer in a Mouse Model of Molybdenum-Cofactor Deficiency  S.
Molecular Therapy - Methods & Clinical Development
Intraspinal AAV Injections Immediately Rostral to a Thoracic Spinal Cord Injury Site Efficiently Transduces Neurons in Spinal Cord and Brain  Michelle.
Volume 4, Issue 6, Pages (December 2001)
Molecular Therapy - Methods & Clinical Development
Molecular Therapy - Methods & Clinical Development
Molecular Therapy - Methods & Clinical Development
Molecular Therapy - Methods & Clinical Development
Xiaoyin Xu, Zhong Yang, Qiang Liu, Yaming Wang  Molecular Therapy 
Volume 9, Issue 5, Pages (November 2017)
Volume 22, Issue 10, Pages (October 2014)
Volume 18, Issue 6, Pages (June 2010)
Volume 36, Issue 2, Pages (January 2016)
A Recombinant Baculovirus Efficiently Generates Recombinant Adeno-Associated Virus Vectors in Cultured Insect Cells and Larvae  Yang Wu, Liangyu Jiang,
Volume 20, Issue 1, Pages (January 2012)
Volume 18, Issue 12, Pages (December 2010)
Volume 16, Issue 2, Pages (July 2016)
Molecular Therapy - Methods & Clinical Development
Antagonism of Myostatin Enhances Muscle Regeneration During Sarcopenia
Volume 18, Issue 4, Pages (April 2010)
Molecular Therapy - Methods & Clinical Development
Volume 16, Issue 12, Pages (December 2008)
Molecular Therapy - Methods & Clinical Development
Molecular Therapy - Methods & Clinical Development
Prevention of Irradiation-induced Salivary Hypofunction by Microvessel Protection in Mouse Salivary Glands  Ana P Cotrim, Anastasia Sowers, James B Mitchell,
Volume 24, Issue 7, Pages (July 2016)
Volume 18, Issue 1, Pages (January 2010)
Volume 15, Issue 9, Pages (September 2007)
Volume 18, Issue 1, Pages (January 2010)
Transduction characteristics of adeno-associated virus vectors expressing cap serotypes 7, 8, 9, and Rh10 in the mouse brain  Cassia N. Cearley, John.
Volume 16, Issue 4, Pages (April 2008)
Computer-assisted Hydrodynamic Gene Delivery
Volume 15, Issue 2, Pages (February 2007)
Volume 6, Issue 5, Pages (November 2002)
Volume 21, Issue 8, Pages (August 2013)
Volume 17, Issue 12, Pages (December 2009)
Volume 10, Issue 4, Pages (October 2004)
Volume 19, Issue 6, Pages (June 2011)
Myogenic Stem Cells Expand in Regenerating Muscle
Volume 18, Issue 3, Pages (March 2010)
372. Targeted Mutagenesis of Ubiquitin-Binding Lysine Residues on the Adeno- Associated Virus (AAV)2 Capsid Improves Its Transduction Efficiency    Molecular.
Kasey L Jackson, Robert D Dayton, Ronald L Klein 
The Lymphocytic Choriomeningitis Virus Envelope Glycoprotein Targets Lentiviral Gene Transfer Vector to Neural Progenitors in the Murine Brain  Colleen.
Volume 6, Issue 3, Pages (September 2002)
Volume 23, Issue 8, Pages (August 2015)
Volume 18, Issue 12, Pages (December 2010)
Volume 18, Issue 6, Pages (June 2010)
Maria P Limberis, Christie L Bell, Jack Heath, James M Wilson 
Volume 20, Issue 9, Pages (September 2012)
Volume 24, Issue 1, Pages (January 2016)
Volume 23, Issue 3, Pages (March 2015)
Molecular Therapy - Methods & Clinical Development
Neuroprotection by Gene Therapy Targeting Mutant SOD1 in Individual Pools of Motor Neurons Does not Translate Into Therapeutic Benefit in fALS Mice  Chris.
Volume 21, Issue 1, Pages (January 2013)
Molecular Therapy - Methods & Clinical Development
Zhijian Wu, Aravind Asokan, R. Jude Samulski  Molecular Therapy 
Volume 11, Issue 1, Pages (January 2005)
Loss of Transgene following ex vivo Gene Transfer is Associated with a Dominant Th2 Response: Implications for Cutaneous Gene Therapy  Zhenmei Lu, Soosan.
Volume 15, Issue 9, Pages (September 2007)
Molecular Therapy - Methods & Clinical Development
Volume 16, Issue 12, Pages (December 2008)
Molecular Therapy - Methods & Clinical Development
Aminoglycoside Enhances the Delivery of Antisense Morpholino Oligonucleotides In Vitro and in mdx Mice  Mingxing Wang, Bo Wu, Sapana N. Shah, Peijuan.
Molecular Therapy - Methods & Clinical Development
Presentation transcript:

Molecular Therapy - Methods & Clinical Development Developmental stage determines efficiency of gene transfer to muscle satellite cells by in utero delivery of adeno-associated virus vector serotype 2/9  David H Stitelman, Tim Brazelton, Archana Bora, Jeremy Traas, Demetri Merianos, Maria Limberis, Marcus Davey, Alan W Flake  Molecular Therapy - Methods & Clinical Development  Volume 1, (January 2014) DOI: 10.1038/mtm.2014.40 Copyright © 2014 American Society of Gene & Cell Therapy Terms and Conditions

Figure 1 Following intravascular injection of AAV9 at E14 with a GFP reporter gene, a mouse examined at P30 under a fluorescent stereomicroscope reveals GFP positive muscles of the (a) upper body, (b) lower body, Panniculus carnosus (PC) muscle underneath the (c) skin, (d) intercostal muscles, (e) diaphragm (Image taken from above the diaphragm) and (f) muscles of the face. Injection at (g) E12 and (h) E14 result in expression of the endocardium of the heart. Injection at (i) E16 and (j) P1 result in expression throughout the entire myocardium. Tibialis anterior muscle, following intravascular injection at (k) E12, (l) E14, (m) E16, and (n) P1. (o–q) E12 injection results in GFP expression in slow twitch fibers (Mab 484 shown in red). (r) E14 injection results in GFP positive myofibers up to 1 year of age. Molecular Therapy - Methods & Clinical Development 2014 1, DOI: (10.1038/mtm.2014.40) Copyright © 2014 American Society of Gene & Cell Therapy Terms and Conditions

Figure 2 Myofibers were isolated from the legs of Myf5-nlacZHet mice injected at E14 with AAV 9 carrying GFP as a reporter and stained with β-galactosidase (βgal) antibody. βgal antibody positive (red), GFP positive cells were observed on the edge of transduced myofibers. (a–c) Transduced GFP positive and untransduced GFP negative satellite cells that are (e–g) βgal positive satellite cells (red) on the edge of a transduced myofiber. Satellite cells migrate off of a transduced myofiber during satellite cell migration assay (fiber loses GFP after dying in the assay). (d) Confocal microscopy of transduced satellite cells in tibialis anterior muscle imaged at 100× of P30 mice following (h–k) E14 and (l–o) E16 injection. βgal in red. GFP in green. β-2-Laminin in blue. Molecular Therapy - Methods & Clinical Development 2014 1, DOI: (10.1038/mtm.2014.40) Copyright © 2014 American Society of Gene & Cell Therapy Terms and Conditions

Figure 3 FACS analysis. Myf5nlacZ/+ mice underwent Intravascular injection with AAV 9 carrying GFP as a reporter gene at E12, E14, E16, and P1. Following myoblast prep of injected legs, cells were analyzed by FACS. Lineage negative cells were gated upon (a). These cells were analyzed for α 7 integrin (y axis) and CD34 (x axis) (b) and revealed two peaks: lineage negative, α 7 positive, and CD34 positive satellite cells and lineage negative, α 7 positive and CD34 negative myoblasts. Animals injected at E12, E14, E16, and P1 were analyzed for GFP positive satellite cells and myoblasts. (c,d) E12 injected myoblasts and satellite cells revealed 0.1 ± 0.1 and 0.2 ± 0.1% GFP transduction respectively. (e,f) E14 injected myoblasts and satellite cells revealed 16.2 ± 3.6 and 13.1 ± 2.6% GFP transduction respectively. (g,h) E16 injected myoblasts and satellite cells revealed 26.6 ± 2.4 and 27.7 ± 10.0% GFP transduction respectively. (i,j) P1 injected myoblasts and satellite cells revealed 2.3 ± 0.3 and 1.8 ± 0.5% GFP transduction respectively. (f) The GFP positive Satellite cells were injected into irradiated Rag mice and following engraftment, injury with notexin and healing failed to show GFP positive muscle fibers but (k) X-gal (blue) cells could be found in the satellite cell position. Molecular Therapy - Methods & Clinical Development 2014 1, DOI: (10.1038/mtm.2014.40) Copyright © 2014 American Society of Gene & Cell Therapy Terms and Conditions